Filter
1719
Filtered Results: 1719
Text search:
European
Medicines
Agency
Featured
Recommendations
161
New Publications
353
Language
Document type
No document type
799
Studies & Reports
412
Guidelines
252
Manuals
107
Strategic & Response Plan
56
Fact sheets
38
Training Material
22
Situation Updates
21
Resource Platforms
5
Brochures
4
App
1
Infographics
1
Online Courses
1
Countries / Regions
Global
94
Western and Central Europe
94
Ukraine
55
Eastern Europe
35
Africa
29
Kenya
28
Ethiopia
25
Ghana
21
Sierra Leone
21
Nigeria
21
Zambia
21
Germany
19
Liberia
19
Myanmar / Burma
19
Nepal
18
Syria
18
Latin America and the Carribbean
18
India
18
Eastern Europe and Central Asia
17
Russia
16
South Africa
15
Guinea
12
South–East Asia Region
12
Philippines
11
Venezuela
11
West and Central Africa
11
Bangladesh
11
Uganda
11
Rwanda
10
Moldova
10
Malawi
9
Zimbabwe
9
East and Southern Africa
9
Tajikistan
8
Senegal
8
Congo, Democratic Republic of
8
Namibia
8
Thailand
7
Tanzania
7
Georgia
7
Indonesia
7
North Macedonia
6
Colombia
6
Burkina Faso
6
Jordan
6
Middle East and North Africa
6
Brazil
6
South Sudan
6
Cameroon
5
Albania
5
Mozambique
5
Cambodia
5
Asia
5
Paraguay
5
Yemen
5
Eswatini/ Swaziland
5
Benin
4
Haiti
4
Hungary
4
Sudan
4
Poland
4
Botswana
4
Somalia
4
Serbia
3
Lesotho
3
Turkey
3
China
3
Kazakhstan
3
Laos
3
Kyrgyzstan
3
Afghanistan
3
USA
3
Jamaica
3
Belarus
3
Lebanon
3
Vietnam
3
Romania
3
Pakistan
3
Chile
2
Iran
2
Estonia
2
Uzbekistan
2
Morocco
2
Bulgaria
2
Western Pacific Region
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Egypt
2
Central African Republic
2
Libya
2
Iraq
2
Madagascar
2
Mexico
1
El Salvador
1
Australia
1
Niger
1
Peru
1
Mongolia
1
Mauritania
1
Armenia
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Southern Africa
1
Papua New Guinea
1
Slovakia
1
Greece
1
Mali
1
Bhutan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
427
Clinical Guidelines
158
Key Resources
104
Public Health
95
Women & Child Health
79
Pharmacy & Technologies
30
Capacity Building
14
Toolboxes
COVID-19
165
Mental Health
164
HIV
137
TB
125
AMR
111
Planetary Health
82
Conflict
74
Rapid Response
71
Pharmacy
59
Refugee
52
Disability
49
Ebola & Marburg
48
Global Health Education
42
NCDs
33
NTDs
32
Caregiver
31
Health Financing Toolbox
31
Specific Hazards
18
Natural Hazards
14
Zika
14
Polio
6
Cholera
3
Malaria
2
Social Ethics
1
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which ...
Front. Trop. Dis. , 09 May 2023 Sec. Neglected Tropical Diseases Volume 4 - 2023 | https://doi.org/10.3389/fitd.2023.1087003
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
The Sphere Handbook. Humanitarian Charter and Minimum Standards in Humanitarian Response. New Edition
recommended
Humanitarian Charter and Minimum Standards in Humanitarian Response.
The 2018 Sphere Handbook builds on the latest developments and learning in the humanitarian sector. Among the improvements of the new edition, readers will find a stronger focus on the role of local authorities and communities as ...
The results of the report clearly show that in 2020, a year dominated by the emergence of COVID-19 and its associated health and economic crises, governments around the world rose to the challenge. Sharp increases in government spending on health at all country income levels underpinned the rise in ...
